DIABETIC AMPUTATIONS: A ‘SHAMEFUL METRIC’ OF INADEQUATE CARE
By Anna Gorman On his regular rounds at the University of Southern California’s Keck Hospital, David Armstrong, MD, lives a brutal injustice of American healthcare. Each week, dozens of patients with diabetes come to him with deep wounds, severe infections and poor circulation — debilitating complications of a disease that
CHRONIC PAIN PATIENTS PUNISHED FOR OPIOID ABUSE BY DOCTORS, PHARMACIES, PAIN CLINICS; GOVERNMENT OVER REACTS
By Blake Farmer Nashville Public Radio A pharmacist in Celina, Tenn., was one of 60 people indicted on charges of opioid-related crimes in April in a multistate sting. John Polston was charged with 21 counts of filling medically unnecessary narcotic prescriptions. He was also Gail Gray’s pharmacist and the person she relied
PELVIC VEIN OBSTRUCTION: VeinCare Centers of Tennessee now implant new BD Venovo stents to open pelvis vein
VeinCare Centers of Tennessee is one of the first clinics in the United States to implant the new BD Venovo stent in obstructed pelvic veins. The Venovo stent is the first stent designed specifically for use in treating obstruction of veins to be approved by the Food and Drug
HHS TO DELIVER VALUE-BASED TRANSFORMATION IN PRIMARY CARE
The U.S. Department of Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma announced the CMS Primary Cares Initiative April 22, a new set of payment models that will transform primary care to deliver better value for patients throughout the
CAN SOMEONE TELL ME WHAT A PBM REALLY DOES?
By Rachel Bluth It was back-to-school day at the Senate Finance Committee hearing April 9. In the third of a series of hearings on rising drug prices, the senators seemed focused on getting an answer to one central question: What the heck is a pharmacy benefit manager? Pharmacy benefit managers,
Teleflex gets premarket OK for biomechanical MANTA Closure
Teleflex Inc., a global provider of medical technologies for critical care and surgery, has announced that it received premarket approval from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial
SVS JOURNAL: EVT IS THE NEW CASH COW FOR NON-VASCULAR DOCTORS; ETHICAL ISSUES RAISED
A new report suggests that providers who are not traditionally associated with the treatment of venous disease are driving the rapid increase in endovenous therapies. A compound annual growth rate of 15 percent has been observed for minimally-invasive procedures to treat superficial venous reflux over the past decade. In the
LETHAL PLANS: When seniors turn to suicide in long-term care
By Melissa Bailey and JoNel Aleccia When Larry Anders moved into the Bay at Burlington nursing home in late 2017, he wasn’t supposed to be there long. At 77, the stoic Wisconsin machinist had just endured the death of his wife of 51 years and a grim new diagnosis: throat
MERZ NORTH AMERICA REGAINS EXCLUSIVE DISTRIBUTION OF ASCLERA (POLIDOCANOL) INJECTION
Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins, effective April 8. Also effective April 8th, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All healthcare professionals will now be able
WHEN MEDICINE MAKES PATIENTS SICKER
By Sydney Lupkin Photos by Heidi de Marco Despite the jackhammer-like rhythm of a mechanical ventilator, Alicia Moreno had dozed off in a chair by her 1-year-old’s hospital bed, when a doctor woke her with some bad news: The common stool softener her son, Anderson, was given months earlier had been